Lindbrook Capital’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15
| Closed | -$20 | – | 2964 |
|
|
2024
Q3 | $20 | Hold |
15
| – | – | ﹤0.01% | 2814 |
|
|
2024
Q2 | $114 | Hold |
15
| – | – | ﹤0.01% | 2714 |
|
|
2024
Q1 | $135 | Hold |
15
| – | – | ﹤0.01% | 2605 |
|
|
2023
Q4 | $161 | Hold |
15
| – | – | ﹤0.01% | 2650 |
|
|
2023
Q3 | $90 | Hold |
15
| – | – | ﹤0.01% | 2652 |
|
|
2023
Q2 | $104 | Hold |
15
| – | – | ﹤0.01% | 2664 |
|
|
2023
Q1 | $236 | Hold |
15
| – | – | ﹤0.01% | 2712 |
|
|
2022
Q4 | $300 | Hold |
15
| – | – | ﹤0.01% | 2679 |
|
|
2022
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 3008 |
|
|
2022
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 2872 |
|
|
2022
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 2657 |
|
|
2021
Q4 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 2035 |
|